Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality

…, PG Swann, A Rosenberg, B Cherney - Journal of …, 2009 - jpharmsci.org
Therapeutic protein products provide unique and effective treatments for numerous human
diseases and medical conditions. In many cases, these treatments are used chronically to …

Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth

SE Pike, L Yao, KD Jones, B Cherney… - The Journal of …, 1998 - rupress.org
An endothelial cell inhibitor was purified from supernatant of an Epstein-Barr virus–immortalized
cell line and identified as fragments of calreticulin. The purified recombinant NH 2 -…

Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo

C Sgadari, AL Angiolillo, BW Cherney… - Proceedings of the …, 1996 - National Acad Sciences
Human Burkitt lymphoma cell lines give rise to progressively growing subcutaneous tumors
in athymic mice. These tumors are induced to regress by inoculation of Epstein–Barr virus-…

The FDA's assessment of follow-on protein products: a historical perspective

J Woodcock, J Griffin, R Behrman, B Cherney… - Nature Reviews Drug …, 2007 - nature.com
The scientific and regulatory issues that are associated with the possible introduction of 'follow-on'
versions of protein drug products are the topic of considerable debate at present. …

Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth

…, L Yao, J Setsuda, KD Jones, B Cherney… - Blood, The Journal …, 1999 - ashpublications.org
Several angiogenesis inhibitors are fragments of larger proteins that are themselves not
active as angiogenesis inhibitors. Vasostatin, the N-terminal domain of calreticulin inclusive of …

cDNA sequence, protein structure, and chromosomal location of the human gene for poly (ADP-ribose) polymerase.

BW Cherney, OW McBride, DF Chen… - Proceedings of the …, 1987 - National Acad Sciences
Recently we described a full-length cDNA for the human nuclear enzyme poly(ADP-ribose)
polymerase. Here, we report the chromosomal localization and partial map of the human …

Managing uncertainty: a perspective on risk pertaining to product quality attributes as they bear on immunogenicity of therapeutic proteins

AS Rosenberg, D Verthelyi, BW Cherney - Journal of pharmaceutical …, 2012 - Elsevier
The critical question addressed in this paper regards how industry and regulatory agencies
should manage the risk of adverse events to patients posed by product quality attributes for …

The role of insertions/deletions in the evolution of the intergenic region betweenpsbA andtrnH in the chloroplast genome

J Aldrich, BW Cherney, E Merlin - Current genetics, 1988 - Springer
TrnH and the intergenic region betweentrnH andpsbA of the chloroplast genomes of alfalfa (Medicago
sativa), Fabaceae, and petunia (Petunia hybrida), Solanaceae, were sequenced …

IL-10 inhibits apoptotic cell death in human T cells starved of IL-2

K Taga, B Cherney, G Tosato - International immunology, 1993 - academic.oup.com
IL-10 was originally described as an inhibitory factor produced by murine T h 2 lymphocytes
that suppresses IFN- γ production by activated murine T h 1 lymphocytes. In this study, we …

Cloning and expression of cDNA for human poly (ADP-ribose) polymerase.

HM Alkhatib, DF Chen, B Cherney… - Proceedings of the …, 1987 - National Acad Sciences
cDNAs encoding poly(ADP-ribose) polymerase from a human hepatoma lambda gt11
cDNA library were isolated by immunological screening. One insert of 1.3 kilobases (kb) …